PNTG Stock Analysis: Buy, Sell, or Hold?

PNTG - The Pennant Group, Inc. Common Stock

SERVICES-HEALTH SERVICES
$27.62
0.28 (1.02%) ▲
HOLD
LOW Confidence
Protect Your PNTG Gains
Last Updated: January 30, 2026
Earnings: Feb 26, 2026 25d

Get Alerted When PNTG Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: PNTG shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$43.73
Based on 9.0% avg growth
INTRINSIC VALUE TODAY
$27.15
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.8x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: PNTG is currently trading at $27.62, which is considered oversold relative to its 30-day fair value range of $27.96 to $29.87. The stock's valuation (Forward PE: 20.9) is in line with its historical norms (21.8). Remarkably, the market is currently pricing in an annual earnings decline of 1.5% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, PNTG is in a strong uptrend. Immediate support is located at $26.66, while resistance sits at $31.94.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (11th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $37.50 (+37.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $27.96 - $29.87
Company Quality Score 53/100 (HOLD)
Options IV Signal 11th percentile (COMPLACENCY WARNING)
Volume Confirmation HIGH
Confidence Score 83.5%

Protect Your Profits

Holding PNTG? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 11th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 37.2% below Wall St target ($37.50)
  • CAUTION: Recommendation downgraded due to -9.5% 5-day decline

Fair Price Analysis

30-Day Fair Range $27.96 - $29.87
Current vs Fair Value OVERSOLD
Expected Move (7 Days) ±$1.75 (6.3%)

Support & Resistance Levels

Support Level $26.67
Resistance Level $31.94
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 20.87
Wall Street Target $37.50 (+37.2%)
Revenue Growth (YoY) 26.8%
Earnings Growth (YoY) -15.0%
Profit Margin 3.1%
Valuation Discount vs History -1.5% cheaper
PE vs Historical 20.9 vs 21.8 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -1.5% (market-implied from PE analysis)
1-Year Target $26.93 (-2%)
2-Year Target $26.53 (-3%)
3-Year Target $26.13 (-4%)
3-Yr Target (if PE normalizes) (PE: 21→22) $27.29 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 13.9%) $43.18 (+58%)
Base: (SPY PE: 20.9, Growth: 13.9%) $40.41 (+48%)
Bear: (PE: 17.7, Growth: 13.9%) $34.35 (+26%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (21x PE) as earnings recover.
Trailing PE: 36.65 | Current EPS (TTM): $0.75
Bull Case $52.82 (+91%)
Analyst growth 74.7%, PE expands to 40.3
Base Case $48.02 (+74%)
Market implied 74.7%, PE stable at 36.7
Bear Case $18.69 (-32%)
Severe decline -20.0%, PE contracts to 31.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.9 to 21.8
Stabilization Target: $28.56 (+4.5%)
PE Expansion Potential: +4.5%
Last updated: January 31, 2026 7:40 AM ET
Data refreshes hourly during market hours. Next update: 8:40 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
HCA
HCA Holdings Inc
BUY
25 analysts
$489 63 BUY
THC
Tenet Healthcare Corpora…
STRONG BUY
22 analysts
$238 54 HOLD
EHC
Encompass Health Corp
STRONG BUY
12 analysts
$140 54 HOLD
CMPS
Compass Pathways Plc
STRONG BUY
11 analysts
$17 52 HOLD
CON
Concentra Group Holdings…
STRONG BUY
8 analysts
$28 62 BUY

Advanced PNTG Option Strategies

Professional options setups generated by AI based on today's PNTG price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PNTG

PNTG Technical Chart PNTG Price Prediction PNTG Earnings Date PNTG Investment Advisor PNTG Fair Price Analyzer PNTG Options Advisor PNTG Options Chain PNTG Options Analysis PNTG Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals